Limbic encephalitis with antibodies against intracellular antigens

Brain and Nerve

Volumn 62, Issue 4, 2010, Pages 347-355

  Morita, Akihiko ^a   Kamei, Satoshi ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Diagnosis; Intracellular antigens; Limbic encephalitis; Paraneoplastic syndromes; Treatment

Indexed keywords

AMPHIPHYSIN; ANTIBODY; CELL ANTIGEN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; HU ANTIBODY; HU ANTIGEN; MA2 ANTIBODY; MA2 ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AGE DISTRIBUTION; ANTIBODY TITER; BRAIN DEGENERATION; BRAIN STEM; BREAST CANCER; CANCER SURGERY; CELLULAR IMMUNITY; CEREBELLUM DEGENERATION; CLINICAL FEATURE; COGNITIVE DEFECT; CYTOTOXIC T LYMPHOCYTE; ENCEPHALOMYELITIS; GAZE PARALYSIS; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; HYPOKINESIA; HYPOTHALAMUS; LIMBIC SYSTEM; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MENTAL DISEASE; NEUROLOGIC DISEASE; PARANEOPLASTIC NEUROPATHY; PROTEIN EXPRESSION; REM SLEEP; REVIEW; SEIZURE; SLEEP DISORDER; SMOKING; TESTIS TUMOR; THYMOMA;

ANTIGENS, NEOPLASM; AUTOANTIBODIES; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LIMBIC ENCEPHALITIS; MALE; NEOPLASMS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77951592475     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 11: 73-87, 1948
2. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340, 2008
3. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003
4. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, et al: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004
5. Bakheit AM, Kennedy PG, Behan PO: Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 53: 1084-1088, 1990
6. Markham M, Abeloff MD: Small-cell lung cancer and limbic encephalitis. Ann Intern Med 96: 785, 1982
7. Aydiner A, Gürvit H, Baral I: Paraneoplastic limbic encephalitis with immature ovarian teratoma - a case report. J Neurooncol 37: 63-66, 1998
8. Cunningham JD, Burt ME: Limbic encephalitis secondary to malignant thymoma. Ann Thorac Surg 58: 250-251, 1994
9. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, et al: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123: 1481-1494, 2000
10. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F: Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54: 530-533, 2003
11. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, et al: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain 127: 701-712, 2004
12. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, et al: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36, 2007 (Pubitemid 46214241)
13. Jarius S, Hoffmann LA, Stich O, Clover L, Rauer S, et al: Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis. J Neurol 255: 1100-1101, 2008
14. Graus F, Keime-Guibert F, Refie R, Benyahia B, Ribalta T, et al: Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124: 1138-1148, 2001
15. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, et al: Limbic encephalitis and small cell lung cancer - Clinical and immunological features. Brain 120: 923-928, 1997
16. Liu J, Dalmau J, Szabo A, Rosenfeld M, Huber J, et al: Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology 45: 544-550, 1995
17. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal, D, et al: Clinical analysis of anti-Ma2-associated encephalitis. Brain 127: 1831-1844, 2004
18. Eker A, Saka E, Dalmau J, Kurne A, Bilen C, et al: Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 79: 1082-1083, 2008
19. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, et al: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340: 1788-1795, 1999
20. Compta Y, Iranzo A, Santamarla J, Casamitjana R, Graus F: REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep 30: 767-769, 2007 (Pubitemid 46854764)
21. Matsumoto L, Yamamoto T, Higashihara M, Sugimoto I, Kowa H, et al: Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes. Mov Disord 22: 728-731, 2007
22. Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, et al: Orchiectomy for suspected microscopic tumor in patients with anti- Ma2-associated encephalitis. Neurology 68: 900-905, 2007
23. Kimura M, Onozawa M, Fujisaki A, Arakawa T, Takeda K, et al: Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin. Int J Urol 15: 942-943, 2008
24. Rojas I, Graus F, Keime-Guibert F, Reñé R, Delattre JY, et al: Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55: 713-715, 2000
25. Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM: Cloning of a leucine-zipper protein recognized by the sera of patients with antibody- associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 88: 3451-3454, 1991
26. Sakai K, Ogasawara T, Hirose G, Jaeckle KA, Greenlee JE: Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. Ann Neurol 33: 373-380, 1993
27. Giometto B, Marchiori GC, Nicolao P, Scaravilli T, Lion A, et al: Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 23: 468-474, 1997
28. Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S: Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 161: 88-90, 1998
29. Buckanovich RJ, Posner JB, Darnell RB: Nova, the paraneoplastic Ri antigen, is homologous to an RNA- binding protein and is specifically expressed in the developing motor system. Neuron 11: 657-672, 1993
30. Buckanovich RJ, Yang YY, Darnell RB: The onconeural antigen Nova-1 is a neuron-specific RNA- binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 16: 1114-1122, 1996
31. Harloff A, Hummel S, Kleinschmidt M, Rauer S: Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung. J Neurol 252: 1404-1405, 2005
32. Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53: 580-587, 2003
33. Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF: Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 61: 270-278, 1996
34. Kellinghaus C, Kraus J, Blaes F, Nabavi DG, Schäbitz WR: CRMP-5-autoantibodies in testicular cancer associated with limbic encephalitis and choreiform dyskinesias. Eur Neurol 57: 241-243, 2007
35. Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, et al: Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80: 412-416, 2009
36. Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, et al: Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62: 778-782, 2004
37. Antoine JC, Absi L, Honnorat J, Boulesteix JM, de Brouker T, et al: Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol 56: 172-177, 1999
38. Dorresteijn LD, Kappelle AC, Renier WO, Gijtenbeek JM: Anti-amphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma. J Neurol 249: 1307-1308, 2002
39. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, et al: Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 58: 96-107, 2005
40. Vernino S, Lennon VA: New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47: 297-305, 2000
41. Knudsen A, Bredholt G, Storstein A, Oltedal L, Davanger S, et al: Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clin Exp Immunol 149: 16-22, 2007
42. Saiz A, Blanco Y, Sabater L, González F, Bataller L, et al: Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131: 2553-2563, 2008
43. Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, et al: Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60: 230-234, 2003
44. Sabater L, Gómez-Choco M, Saiz A, Graus F: BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis. J Neuroimmunol 170: 186-190, 2005
45. Tüzün E, Rossi JE, Karner SF, Centurion AF, Dalmau J: Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J Neuroimmunol 186: 177-180, 2007
46. Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S: Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163: 159-162, 1999
47. Tanaka M, Maruyama Y, Sugie M, Motizuki H, Kamakura K, et al: Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurol Sci 201: 9-12, 2002
48. Tanaka M, Tanaka K, Tsuji S, Kawata A, Kojima S, et al: Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. J Neurol Sci 188: 61-65, 2001
49. Saiki M, Sakai K, Saiki S, Kitagawa Y, Nakanishi M, et al: Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization. J Autoimmun 24: 203-208, 2005
50. Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, et al: Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682-690, 2006 (Pubitemid 44139368)